Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.

被引：0
|
作者：
Mueller, TJ
Hermann, J
Fahrleitner, A
Yazdani-Biuki, B
Dimai, HP
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1076
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [1] Effects of the TNF-alpha antibody infliximab on serum markers of bone turnover and mineral metabolism in patients with rheumatoid arthritis
    Dimai, HP
    Müller, T
    Eder, S
    Hermann, J
    BONE, 2001, 28 (05) : S179 - S180
  • [2] Effect of infliximab on markers of bone metabolism in patients with rheumatoid arthritis.
    Vis, M
    Wolbink, GJ
    van Soesbergen, RM
    Lodder, MC
    van der Stadt, RJ
    Dijkmans, BAC
    Lems, WF
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S478 - S478
  • [3] Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
    Chopin, F.
    Garnero, P.
    le Henanff, A.
    Debiais, F.
    Daragon, A.
    Roux, C.
    Sany, J.
    Wendling, D.
    Zarnitsky, C.
    Ravaud, P.
    Thomas, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 353 - 357
  • [4] Effects of the anti-TNF-antibody infliximab on nitric oxide (NO) synthesis by synovial membrane and cartiladge in adjuvant arthritis
    Dubilkov, AI
    Cherepovsky, AV
    Belogolovyh, LA
    Medved, EE
    Nikulin, SV
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 151 - 151
  • [5] Positive effects of infliximab therapy on bone metabolism in patients with rheumatoid arthritis.
    Thomas, T
    Garnero, P
    le Henanff, A
    Debiais, F
    Le Loet, X
    Roux, C
    Sany, J
    Wendling, D
    Zarnitsky, C
    Ravaux, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S333 - S333
  • [6] RANKL inhibition with denosumab decreases markers of bone and cartilage turnover in patients with rheumatoid arthritis.
    Lane, N. E.
    Iannini, M.
    Atkins, C.
    Haraoui, B.
    Zhou, L.
    Tsuji, W.
    Newmark, R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S225 - S226
  • [7] EFFECTS OF ANTI-TNF AGENTS ON BONE DENSITY AND MARKERS OF BONE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Malaiya, Ritu
    Rachapalli, Satish M.
    RHEUMATOLOGY, 2010, 49 : I91 - I91
  • [8] Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
    Adami, Giovanni
    Orsolini, Giovanni
    Rossini, Maurizio
    Fratucello, Anna
    Fassio, Angelo
    Viapiana, Ombretta
    Fracassi, Elena
    Bixio, Riccardo
    Gatti, Davide
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [9] Does infliximab decrease bone turnover in rheumatoid arthritis patients
    Korczowska, I
    Hrycaj, P
    Lacki, JK
    JOINT BONE SPINE, 2003, 70 (05) : 398 - 400
  • [10] Impact of treatment with infliximab on anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Mubashir, E
    Ahmed, MM
    Wolf, RE
    Hayat, S
    Hall, VC
    Shi, R
    Berney, SM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4098 - 4098
12345